Jared Klarquist
Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 11 | 2025 | 914 | 1.990 |
Why?
| | B-Lymphocytes | 5 | 2025 | 875 | 1.640 |
Why?
| | T-Lymphocytes, Helper-Inducer | 4 | 2021 | 130 | 1.420 |
Why?
| | Lupus Erythematosus, Systemic | 4 | 2020 | 237 | 1.390 |
Why?
| | Immunologic Memory | 4 | 2025 | 366 | 1.380 |
Why?
| | Vitiligo | 8 | 2016 | 42 | 1.290 |
Why?
| | Vaccines, Subunit | 2 | 2021 | 53 | 1.220 |
Why?
| | T-Lymphocytes, Regulatory | 6 | 2025 | 388 | 0.830 |
Why?
| | Spike Glycoprotein, Coronavirus | 2 | 2021 | 130 | 0.780 |
Why?
| | Interleukin-27 | 1 | 2021 | 13 | 0.690 |
Why?
| | Interferon Type I | 2 | 2020 | 144 | 0.680 |
Why?
| | Skin | 5 | 2016 | 751 | 0.660 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2021 | 175 | 0.620 |
Why?
| | Mice, Inbred C57BL | 17 | 2025 | 5954 | 0.600 |
Why?
| | gp100 Melanoma Antigen | 3 | 2016 | 3 | 0.580 |
Why?
| | Chemokine CCL22 | 1 | 2016 | 3 | 0.500 |
Why?
| | Melanoma | 5 | 2016 | 757 | 0.490 |
Why?
| | Dendritic Cells | 4 | 2016 | 496 | 0.490 |
Why?
| | Receptors, Antigen, T-Cell | 3 | 2016 | 667 | 0.450 |
Why?
| | Mice | 20 | 2025 | 18218 | 0.440 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4525 | 0.430 |
Why?
| | Lymphangioleiomyomatosis | 2 | 2013 | 36 | 0.390 |
Why?
| | Autoimmunity | 3 | 2025 | 928 | 0.370 |
Why?
| | Animals | 23 | 2025 | 37800 | 0.370 |
Why?
| | Mice, Knockout | 9 | 2025 | 3106 | 0.360 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 440 | 0.350 |
Why?
| | T-Lymphocytes | 2 | 2018 | 1981 | 0.330 |
Why?
| | T-Lymphocytes, Cytotoxic | 3 | 2011 | 177 | 0.320 |
Why?
| | Membrane Glycoproteins | 2 | 2010 | 495 | 0.310 |
Why?
| | Melanocytes | 5 | 2014 | 65 | 0.290 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2009 | 221 | 0.290 |
Why?
| | T-Lymphocyte Subsets | 4 | 2014 | 412 | 0.280 |
Why?
| | CD4-Positive T-Lymphocytes | 5 | 2021 | 1129 | 0.280 |
Why?
| | Membrane Proteins | 1 | 2014 | 1158 | 0.270 |
Why?
| | Forkhead Box Protein O1 | 2 | 2025 | 35 | 0.270 |
Why?
| | Antigens, Neoplasm | 1 | 2009 | 271 | 0.270 |
Why?
| | DNA | 1 | 2014 | 1444 | 0.270 |
Why?
| | Hepatitis C | 5 | 2008 | 254 | 0.270 |
Why?
| | Vaccination | 4 | 2021 | 1416 | 0.260 |
Why?
| | Germinal Center | 2 | 2020 | 67 | 0.260 |
Why?
| | Hepacivirus | 5 | 2008 | 243 | 0.250 |
Why?
| | Up-Regulation | 4 | 2018 | 847 | 0.230 |
Why?
| | Hepatitis C, Chronic | 4 | 2008 | 152 | 0.230 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2025 | 23 | 0.230 |
Why?
| | Gangliosides | 2 | 2016 | 23 | 0.220 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.220 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 93 | 0.210 |
Why?
| | Th17 Cells | 1 | 2025 | 100 | 0.210 |
Why?
| | Receptors, CCR4 | 2 | 2016 | 23 | 0.200 |
Why?
| | Flow Cytometry | 5 | 2017 | 1152 | 0.200 |
Why?
| | Interleukin-15 | 2 | 2025 | 96 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 262 | 0.190 |
Why?
| | Lysophospholipids | 1 | 2023 | 78 | 0.190 |
Why?
| | Colon | 1 | 2025 | 307 | 0.180 |
Why?
| | Colitis | 1 | 2025 | 280 | 0.180 |
Why?
| | Phenols | 3 | 2014 | 107 | 0.180 |
Why?
| | Lymphocyte Count | 1 | 2021 | 164 | 0.170 |
Why?
| | Intestinal Mucosa | 2 | 2025 | 675 | 0.170 |
Why?
| | Receptors, Virus | 1 | 2021 | 96 | 0.170 |
Why?
| | HSP70 Heat-Shock Proteins | 2 | 2014 | 76 | 0.160 |
Why?
| | Mice, Transgenic | 5 | 2018 | 2177 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 11 | 0.160 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2020 | 34 | 0.150 |
Why?
| | Humans | 30 | 2025 | 144298 | 0.150 |
Why?
| | Transcriptional Activation | 2 | 2018 | 372 | 0.150 |
Why?
| | Neoplasms | 1 | 2014 | 2860 | 0.140 |
Why?
| | Aerobiosis | 1 | 2018 | 21 | 0.140 |
Why?
| | Vaccinia | 1 | 2018 | 20 | 0.140 |
Why?
| | Female | 18 | 2025 | 78137 | 0.140 |
Why?
| | Multiple Sclerosis | 1 | 2024 | 483 | 0.140 |
Why?
| | Ovalbumin | 1 | 2018 | 190 | 0.140 |
Why?
| | Orthomyxoviridae Infections | 1 | 2018 | 72 | 0.130 |
Why?
| | Cells, Cultured | 4 | 2020 | 4102 | 0.130 |
Why?
| | Antiviral Agents | 3 | 2008 | 764 | 0.130 |
Why?
| | Receptors, Interleukin-17 | 1 | 2017 | 6 | 0.130 |
Why?
| | B7-H1 Antigen | 2 | 2018 | 241 | 0.130 |
Why?
| | Sialyltransferases | 1 | 2016 | 13 | 0.130 |
Why?
| | Adjuvants, Immunologic | 1 | 2018 | 245 | 0.130 |
Why?
| | Housing, Animal | 1 | 2017 | 46 | 0.120 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2018 | 167 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2008 | 185 | 0.120 |
Why?
| | Interleukins | 1 | 2018 | 248 | 0.120 |
Why?
| | Killer Cells, Natural | 1 | 2020 | 467 | 0.120 |
Why?
| | Macrophages, Peritoneal | 1 | 2016 | 89 | 0.120 |
Why?
| | Stress, Physiological | 2 | 2017 | 446 | 0.120 |
Why?
| | Glycolysis | 1 | 2018 | 340 | 0.120 |
Why?
| | Transcription Factor RelA | 1 | 2016 | 85 | 0.120 |
Why?
| | Male | 16 | 2025 | 72263 | 0.120 |
Why?
| | Epidermis | 2 | 2014 | 157 | 0.120 |
Why?
| | Melanoma, Experimental | 1 | 2016 | 109 | 0.120 |
Why?
| | Jurkat Cells | 1 | 2016 | 114 | 0.120 |
Why?
| | CD8 Antigens | 1 | 2015 | 70 | 0.110 |
Why?
| | Diet, High-Fat | 1 | 2017 | 261 | 0.110 |
Why?
| | Intramolecular Oxidoreductases | 3 | 2011 | 65 | 0.110 |
Why?
| | Clone Cells | 1 | 2016 | 263 | 0.110 |
Why?
| | Cell Proliferation | 3 | 2025 | 2485 | 0.110 |
Why?
| | Cell Death | 2 | 2014 | 382 | 0.110 |
Why?
| | Allergens | 1 | 2018 | 386 | 0.110 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2018 | 216 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2017 | 276 | 0.110 |
Why?
| | Cloning, Molecular | 1 | 2016 | 534 | 0.110 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2014 | 16 | 0.110 |
Why?
| | Plaque, Atherosclerotic | 1 | 2015 | 60 | 0.110 |
Why?
| | Hyperlipidemias | 1 | 2015 | 120 | 0.110 |
Why?
| | Hypopigmentation | 1 | 2014 | 3 | 0.110 |
Why?
| | Base Sequence | 2 | 2016 | 2171 | 0.110 |
Why?
| | Skin Pigmentation | 3 | 2011 | 48 | 0.110 |
Why?
| | Antigens, CD | 2 | 2008 | 552 | 0.110 |
Why?
| | B-Lymphocyte Subsets | 1 | 2014 | 79 | 0.100 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2017 | 265 | 0.100 |
Why?
| | Hydroquinones | 2 | 2014 | 29 | 0.100 |
Why?
| | Pigmentation | 1 | 2014 | 52 | 0.100 |
Why?
| | Mutation | 1 | 2025 | 4068 | 0.100 |
Why?
| | Temperature | 1 | 2017 | 675 | 0.100 |
Why?
| | Immunity | 1 | 2014 | 139 | 0.100 |
Why?
| | Skin Neoplasms | 2 | 2011 | 848 | 0.090 |
Why?
| | Antigens | 1 | 2014 | 346 | 0.090 |
Why?
| | Oxidoreductases | 2 | 2011 | 95 | 0.090 |
Why?
| | Interferon-gamma | 4 | 2008 | 781 | 0.090 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2012 | 152 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1437 | 0.090 |
Why?
| | HSP72 Heat-Shock Proteins | 1 | 2011 | 31 | 0.090 |
Why?
| | Atherosclerosis | 1 | 2015 | 408 | 0.090 |
Why?
| | Neoplasms, Experimental | 1 | 2012 | 167 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 832 | 0.090 |
Why?
| | Ribavirin | 2 | 2008 | 80 | 0.080 |
Why?
| | Signal Transduction | 3 | 2025 | 5182 | 0.080 |
Why?
| | Heme Oxygenase-1 | 1 | 2011 | 74 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2018 | 1483 | 0.080 |
Why?
| | Sepsis | 1 | 2016 | 642 | 0.080 |
Why?
| | Receptors, CCR8 | 1 | 2010 | 2 | 0.080 |
Why?
| | Interferon-alpha | 2 | 2008 | 194 | 0.080 |
Why?
| | Forkhead Transcription Factors | 2 | 2008 | 201 | 0.080 |
Why?
| | MART-1 Antigen | 1 | 2009 | 8 | 0.080 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 2010 | 99 | 0.080 |
Why?
| | Receptors, CCR5 | 1 | 2010 | 60 | 0.080 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2009 | 154 | 0.070 |
Why?
| | Macrophages | 1 | 2016 | 1496 | 0.070 |
Why?
| | Cell Separation | 1 | 2009 | 302 | 0.070 |
Why?
| | Immunotherapy, Adoptive | 1 | 2012 | 338 | 0.070 |
Why?
| | Convalescence | 1 | 2007 | 19 | 0.070 |
Why?
| | Autoimmune Diseases | 2 | 2011 | 462 | 0.070 |
Why?
| | Interleukin-2 | 2 | 2025 | 436 | 0.070 |
Why?
| | Disease Transmission, Infectious | 1 | 2007 | 68 | 0.060 |
Why?
| | RNA, Viral | 3 | 2024 | 687 | 0.060 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2006 | 11 | 0.060 |
Why?
| | Adult | 9 | 2016 | 40408 | 0.060 |
Why?
| | Receptors, Interleukin-7 | 1 | 2006 | 28 | 0.060 |
Why?
| | Epitopes | 3 | 2015 | 479 | 0.060 |
Why?
| | Polyethylene Glycols | 2 | 2008 | 651 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2013 | 1314 | 0.060 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1699 | 0.060 |
Why?
| | STAT5 Transcription Factor | 1 | 2025 | 49 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 46 | 0.060 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 40 | 0.050 |
Why?
| | Immunotherapy | 1 | 2009 | 659 | 0.050 |
Why?
| | Obesity | 1 | 2017 | 3068 | 0.050 |
Why?
| | Inflammation | 3 | 2025 | 2862 | 0.050 |
Why?
| | Monitoring, Immunologic | 1 | 2023 | 24 | 0.050 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2023 | 40 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 971 | 0.050 |
Why?
| | Middle Aged | 9 | 2014 | 35892 | 0.050 |
Why?
| | Listeria monocytogenes | 1 | 2023 | 114 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2013 | 2643 | 0.040 |
Why?
| | Cell Survival | 2 | 2014 | 1092 | 0.040 |
Why?
| | Adolescent | 4 | 2014 | 22370 | 0.030 |
Why?
| | Mitochondria | 1 | 2025 | 981 | 0.030 |
Why?
| | Jejunum | 1 | 2017 | 36 | 0.030 |
Why?
| | Cytokines | 1 | 2025 | 2043 | 0.030 |
Why?
| | Th1 Cells | 2 | 2008 | 139 | 0.030 |
Why?
| | Sex Factors | 2 | 2017 | 2103 | 0.030 |
Why?
| | Young Adult | 2 | 2014 | 14092 | 0.030 |
Why?
| | Biolistics | 1 | 2016 | 2 | 0.030 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 37 | 0.030 |
Why?
| | Permeability | 1 | 2017 | 168 | 0.030 |
Why?
| | Gram-Negative Bacteria | 1 | 2017 | 80 | 0.030 |
Why?
| | Vaccines, DNA | 1 | 2016 | 31 | 0.030 |
Why?
| | Viremia | 2 | 2008 | 158 | 0.030 |
Why?
| | Cytomegalovirus | 2 | 2007 | 168 | 0.030 |
Why?
| | Corticosterone | 1 | 2017 | 242 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2016 | 3520 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2024 | 2808 | 0.030 |
Why?
| | Cold Temperature | 1 | 2017 | 208 | 0.030 |
Why?
| | Receptors, LDL | 1 | 2015 | 53 | 0.030 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 42 | 0.030 |
Why?
| | Disease Progression | 2 | 2017 | 2844 | 0.030 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2008 | 264 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2023 | 2033 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1726 | 0.030 |
Why?
| | Monophenol Monooxygenase | 1 | 2014 | 7 | 0.030 |
Why?
| | Stem Cell Factor | 1 | 2014 | 16 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2016 | 390 | 0.030 |
Why?
| | Alleles | 2 | 2008 | 881 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2008 | 1360 | 0.030 |
Why?
| | Antigen Presentation | 1 | 2015 | 205 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2015 | 320 | 0.030 |
Why?
| | Melanosomes | 1 | 2014 | 2 | 0.030 |
Why?
| | Trans-Activators | 1 | 2016 | 397 | 0.030 |
Why?
| | Acute Disease | 2 | 2008 | 1029 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 741 | 0.030 |
Why?
| | Subcellular Fractions | 1 | 2014 | 73 | 0.030 |
Why?
| | Hematopoietic Stem Cells | 1 | 2017 | 419 | 0.030 |
Why?
| | Intracellular Space | 1 | 2014 | 64 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2014 | 118 | 0.020 |
Why?
| | Transgenes | 1 | 2014 | 190 | 0.020 |
Why?
| | Spleen | 1 | 2015 | 507 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2016 | 619 | 0.020 |
Why?
| | Antigens, CD1d | 1 | 2013 | 68 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2016 | 854 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2013 | 3595 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2015 | 500 | 0.020 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 67 | 0.020 |
Why?
| | HLA-A2 Antigen | 1 | 2012 | 35 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2016 | 770 | 0.020 |
Why?
| | Protein Transport | 1 | 2014 | 436 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2015 | 428 | 0.020 |
Why?
| | CD3 Complex | 1 | 2012 | 111 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1244 | 0.020 |
Why?
| | Bleaching Agents | 1 | 2011 | 1 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 881 | 0.020 |
Why?
| | Langerhans Cells | 1 | 2011 | 12 | 0.020 |
Why?
| | PUVA Therapy | 1 | 2011 | 6 | 0.020 |
Why?
| | Heme Oxygenase (Decyclizing) | 1 | 2011 | 21 | 0.020 |
Why?
| | Machine Learning | 1 | 2017 | 587 | 0.020 |
Why?
| | Administration, Topical | 1 | 2011 | 152 | 0.020 |
Why?
| | Longitudinal Studies | 2 | 2008 | 2940 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1762 | 0.020 |
Why?
| | Annexin A5 | 1 | 2010 | 21 | 0.020 |
Why?
| | DNA Fragmentation | 1 | 2010 | 39 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2010 | 149 | 0.020 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2010 | 85 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2017 | 771 | 0.020 |
Why?
| | Caspase 3 | 1 | 2010 | 233 | 0.020 |
Why?
| | Necrosis | 1 | 2010 | 243 | 0.020 |
Why?
| | Cell Line | 1 | 2014 | 2821 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2011 | 264 | 0.020 |
Why?
| | Autoantigens | 1 | 2011 | 425 | 0.020 |
Why?
| | Keratinocytes | 1 | 2010 | 250 | 0.020 |
Why?
| | Fibrinogens, Abnormal | 1 | 2008 | 2 | 0.020 |
Why?
| | Ultraviolet Rays | 1 | 2011 | 383 | 0.020 |
Why?
| | CD24 Antigen | 1 | 2008 | 18 | 0.020 |
Why?
| | Remission, Spontaneous | 1 | 2007 | 39 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 80 | 0.020 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 1 | 2007 | 14 | 0.020 |
Why?
| | CD57 Antigens | 1 | 2007 | 18 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2008 | 396 | 0.020 |
Why?
| | Genes, MHC Class II | 1 | 2007 | 76 | 0.020 |
Why?
| | Antioxidants | 1 | 2011 | 542 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2007 | 137 | 0.020 |
Why?
| | Cohort Studies | 2 | 2008 | 5948 | 0.020 |
Why?
| | Blood | 1 | 2007 | 106 | 0.020 |
Why?
| | Age Distribution | 1 | 2007 | 402 | 0.020 |
Why?
| | HLA Antigens | 1 | 2008 | 231 | 0.020 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2008 | 201 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2008 | 393 | 0.020 |
Why?
| | Immunoglobulin M | 1 | 2007 | 280 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 2008 | 272 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2007 | 376 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2008 | 1044 | 0.010 |
Why?
| | Cytomegalovirus Infections | 1 | 2007 | 205 | 0.010 |
Why?
| | Viral Load | 1 | 2007 | 527 | 0.010 |
Why?
| | Aged, 80 and over | 2 | 2008 | 8265 | 0.010 |
Why?
| | Prospective Studies | 2 | 2008 | 7972 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1046 | 0.010 |
Why?
| | RNA | 1 | 2011 | 926 | 0.010 |
Why?
| | Fibroblasts | 1 | 2010 | 1017 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2011 | 1331 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2007 | 671 | 0.010 |
Why?
| | Sexual Behavior | 1 | 2007 | 492 | 0.010 |
Why?
| | Genotype | 1 | 2008 | 1843 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 2113 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2014 | 6387 | 0.010 |
Why?
| | Apoptosis | 1 | 2010 | 2395 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2007 | 1501 | 0.010 |
Why?
| | Lung | 1 | 2013 | 4084 | 0.010 |
Why?
| | Liver | 1 | 2007 | 1884 | 0.010 |
Why?
| | Biomarkers | 1 | 2010 | 4248 | 0.010 |
Why?
| | Phenotype | 1 | 2006 | 3139 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2007 | 6035 | 0.010 |
Why?
| | Risk Factors | 1 | 2007 | 10783 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2008 | 11713 | 0.010 |
Why?
| | United States | 1 | 2007 | 15979 | 0.000 |
Why?
| | Aged | 1 | 2007 | 25901 | 0.000 |
Why?
|
|
Klarquist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|